💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
User | Tweets |
---|---|
@OmarPridelands | 35 |
@1000Shares | 7 |
@Gambiste1 | 6 |
@MarcJacksonLA | 3 |
@OilStocker | 2 |
![]() |
@OmarPridelands $gern check out imetelchat https://t.co/PFRgJ25q4D April 19th 2021, 9:04pm |
![]() |
@ChartMill A Quick Ratio of 6.46 indicates that $GERN has no problem at all paying its short term obligations.… https://t.co/q4eIH7pR4o April 19th 2021, 2:04am |
![]() |
@FlashAlert_me $GERN [15s. delayed]: Issued Press Release on April 18, 08:00:00: Lifshitz Law Firm, P.C. Announces Investigations… https://t.co/3v7mN3sa6L April 18th 2021, 12:04pm |
![]() |
@OmarPridelands $gern https://t.co/0m8MvcJZaB April 17th 2021, 3:04am |
![]() |
@OmarPridelands RT @TMAN1138pm: $GERN #Bloodcancer #Imetelstat April 16th 2021, 7:04pm |
![]() |
@TMAN1138pm $GERN #Bloodcancer #Imetelstat https://t.co/Z6aA0Vx4Qk April 16th 2021, 5:04pm |
![]() |
@MarcJacksonLA $GERN Phase 3 Study of Imtelstat Versus BAT Explores Survival Improvement in Myelofibrosis https://t.co/FRI1DA2WuL via @targetedonc April 15th 2021, 8:04pm |
![]() |
@OmarPridelands RT @hadidy_sara: $GERN: Signals could not be any clearer on the 1-minute chart of GERN. Awaiting Buy Signal https://t.co/uLmwgJaeyx April 15th 2021, 2:04pm |
![]() |
@hadidy_sara $GERN: Signals could not be any clearer on the 1-minute chart of GERN. Awaiting Buy Signal https://t.co/uLmwgJaeyx April 15th 2021, 9:04am |
![]() |
@OmarPridelands RT @newsfilterio: Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis $GERN https://t.co/mV4… April 14th 2021, 2:04pm |
![]() |
@OmarPridelands RT @1stOncology: #Geron Announces First Patient Dosed in #IMpactMF Phase 3 Clinical Trial in #Refractory #Myelofibrosis $GERN https://t.co/… April 14th 2021, 2:04pm |
![]() |
@1stOncology #Geron Announces First Patient Dosed in #IMpactMF Phase 3 Clinical Trial in #Refractory #Myelofibrosis $GERN https://t.co/wEv1bVVfEh April 14th 2021, 10:04am |
![]() |
@newsfilterio Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis $GERN https://t.co/mV4QLJWFDC April 14th 2021, 7:04am |
![]() |
@newsfilterio Geron starts dosing in late-stage blood cancer study $GERN https://t.co/s8i4CHbCnU April 14th 2021, 7:04am |
![]() |
@OmarPridelands @StockLizardKing $gern April 13th 2021, 11:04pm |
![]() |
@OmarPridelands RT @SmallCapsDaily: $GERN Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis Business Wire… April 13th 2021, 6:04pm |
![]() |
@OmarPridelands RT @equity_newswire: $GERN Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis https://t.co/… April 13th 2021, 6:04pm |
![]() |
@OmarPridelands RT @HillScottW: $GERN Yuge drop in short interest and now this? nothing has changed. nice lotto https://t.co/p8wuxVWvbo April 13th 2021, 6:04pm |
![]() |
@HillScottW $GERN Yuge drop in short interest and now this? nothing has changed. nice lotto https://t.co/p8wuxVWvbo April 13th 2021, 6:04pm |
![]() |
@equity_newswire $GERN Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis https://t.co/C7E3XS3886 April 13th 2021, 5:04pm |
![]() |
@SmallCapsDaily $GERN Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis Business W… https://t.co/bHVUBIPLp9 April 13th 2021, 3:04pm |
![]() |
@OmarPridelands RT @stock_titan: $GERN Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis https://t.co/DQ49… April 13th 2021, 2:04pm |
![]() |
@OmarPridelands RT @TeamofStockTra: $GERN - Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis April 13th 2021, 2:04pm |
![]() |
@OmarPridelands RT @AkramMSiddique: $GERN - Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis April 13th 2021, 2:04pm |
![]() |
@OmarPridelands RT @FlashAlert_me: $GERN [15s. delayed]: Issued Press Release on April 13, 07:30:00: Geron Announces First Patient Dosed in IMpactMF Phase… April 13th 2021, 2:04pm |
![]() |
@OmarPridelands RT @sbwcws: Geron announces first patient dosed in IMpactMF trial $GERN April 13th 2021, 2:04pm |
![]() |
@OmarPridelands RT @CHItraders: $GERN Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis | Business Wire ht… April 13th 2021, 2:04pm |
![]() |
@OmarPridelands RT @Beeken_health: $GERN - Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis https://t.co/… April 13th 2021, 2:04pm |
![]() |
@OmarPridelands RT @MarketCurrents: $GERN - Geron starts dosing in late-stage blood cancer study https://t.co/LEA3m8hrcf April 13th 2021, 2:04pm |
![]() |
@OmarPridelands RT @moneymessage_: $GERN - Geron starts dosing in late-stage blood cancer study https://t.co/nFMKyDfJJc April 13th 2021, 2:04pm |
![]() |
@MarcJacksonLA $GERN Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis | Business… https://t.co/vF92MjLyT9 April 13th 2021, 2:04pm |
![]() |
@moneymessage_ $GERN - Geron starts dosing in late-stage blood cancer study https://t.co/nFMKyDfJJc April 13th 2021, 1:04pm |
![]() |
@OilStocker $GERN @ $1.42 2021-04-13 @ 8:15 AM EST Geron Doses First Patient in Phase 3 Study of Potential Blood Cancer Drug I… https://t.co/ps18RNXskp April 13th 2021, 12:04pm |
![]() |
@OilStocker $GERN @ $1.42 2021-04-13 @ 7:30 AM EST Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis April 13th 2021, 12:04pm |
![]() |
@MarketCurrents $GERN - Geron starts dosing in late-stage blood cancer study https://t.co/LEA3m8hrcf April 13th 2021, 11:04am |
![]() |
@Beeken_health $GERN - Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis… https://t.co/ecNqqT9Hmc April 13th 2021, 11:04am |
![]() |
@CHItraders $GERN Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis | Business… https://t.co/frdz7xFh9y April 13th 2021, 11:04am |
![]() |
@sbwcws Geron announces first patient dosed in IMpactMF trial $GERN April 13th 2021, 11:04am |
![]() |
@FlashAlert_me $GERN [15s. delayed]: Issued Press Release on April 13, 07:30:00: Geron Announces First Patient Dosed in IMpactMF P… https://t.co/iFqNIv5jJ7 April 13th 2021, 11:04am |
![]() |
@AkramMSiddique $GERN - Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis April 13th 2021, 11:04am |
![]() |
@stock_titan $GERN Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis… https://t.co/EDG9B4lEk5 April 13th 2021, 11:04am |
![]() |
@Gambiste1 RT @_sdrawkcabeman_: The Dec 10th ASH 2018 CC Part 2 of 8 $GERN https://t.co/e8NHrjpHUr April 10th 2021, 6:04pm |
![]() |
@Gambiste1 RT @_sdrawkcabeman_: The Dec 10th ASH 2018 CC Part 1 of 8 $GERN https://t.co/jlIrSVwoDq April 10th 2021, 6:04pm |
![]() |
@Gambiste1 RT @_sdrawkcabeman_: A note on Imerge, Part1/3. $GERN 7/13(54%) TI in original. PREMATURE expansion data was 7/25(28%); but mean burden=6… April 10th 2021, 6:04pm |
![]() |
@Gambiste1 RT @_sdrawkcabeman_: A note on Imerge, Part2/3. $GERN HI-E =71% w/68% reduction! +today's data says mTI not yet reached, data STILL DEVELO… April 10th 2021, 6:04pm |
![]() |
@Gambiste1 RT @_sdrawkcabeman_: A note on Imerge, Part3/3. $GERN Incredible DEPTH of response gives me sufficient reason to blve more pts w/mean 2 ex… April 10th 2021, 6:04pm |
![]() |
@OmarPridelands RT @_sdrawkcabeman_: The Dec 10th ASH 2018 CC Part 3 of 8 $GERN https://t.co/HEYi7Uc1fT April 10th 2021, 6:04pm |
![]() |
@OmarPridelands RT @_sdrawkcabeman_: The Dec 10th ASH 2018 CC Part 4 of 8 $GERN https://t.co/QdeTG5U2Ia April 10th 2021, 6:04pm |
![]() |
@OmarPridelands RT @_sdrawkcabeman_: The Dec 10th ASH 2018 CC Part 5 of 8 $GERN https://t.co/4kAkEbZE2Q April 10th 2021, 6:04pm |
![]() |
@OmarPridelands RT @_sdrawkcabeman_: The Dec 10th ASH 2018 CC Part 6 of 8 $GERN https://t.co/yzy7QFx9DU April 10th 2021, 6:04pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.